Choose your Region

Are you sure you want to proceed?

You will be leaving the Cook Medical website that you were viewing and going to a Cook Medical website for another region or country. Not all products are approved in all regulatory jurisdictions. The product information on these websites is intended only for licensed physicians and healthcare professionals.

Part 2 – Patient selection, referral pathway, and TIPS techniques


View part 1 View part 3 See the full webinar and transcript
 

Cook Medical sponsored a webinar discussion between specialists in interventional radiology and hepatology on the need for early transjugular intrahepatic portosystemic shunt (TIPS) procedures in patients with portal hypertension.

The program was moderated by Dr. David Patch from the Royal Free Hospital in London and Prof. Otto M. van Delden from Amsterdam University Medical Center. Speakers included Prof. Bernhard Gebauer, director of the interventional radiology department at Charité Campus Virchow Clinic in Berlin; Dr. Virginia Hernández-Gea from the Liver Unit at Hospital Clínic-IDIBAPS in Barcelona; and Dr. Antonio Gaetano Rampoldi from Niguarda Hospital in Milan.

Hepatologist Dr. Hernández-Gea, an expert on portal hypertension, discussed the role of TIPS in patients with variceal bleeding. She noted that there is no indication for TIPS as a primary prophylactic treatment.

6315670614112
brightcove
true

Acute variceal bleeding

According to Dr. Hernández-Gea, when a patient has acute variceal bleeding, there are two main treatment options:

  • Rescue (salvage) TIPS to stop bleeding or multiple re-bleeding episodes and return the patient to a non-emergent scenario
  • Preemptive TIPS to prevent failure of bleeding and stabilize a high-risk patient
 

Rescue TIPS

Patients selected to undergo rescue TIPS include those who are intubated with heavy drug support and massive, uncontrolled bleeding, and patients experiencing a failure of bridge therapy (balloon tamponade or esophageal stent). “This is a very critical scenario where the mortality is very high,” she said.

Preemptive TIPS

Dr. Hernández-Gea explained that 20% of patients with variceal bleeding will respond to the treatment but are at risk of early re-bleeding.

Therefore, preemptive TIPS must be placed in these high-risk patients as soon as possible to prevent re-bleeding, failure, and mortality. A landmark study1 showed bleeding and mortality is concentrated in the first three days, especially in the first 24–48 hours.

6315668463112
brightcove
true

High-risk patients

According to Dr. Hernández-Gea, there are three scores that will help physicians determine that patients should receive preemptive TIPS: an HVPG greater than 20 mmHG, a Child-Pugh C score less than 14, and a Child-Pugh B score greater than 7 with active bleeding at endoscopy.

6315670635112
brightcove
true

Patient stratification

Based on the study by Nicoara-Farcau O, et al.,2 patient stratification helps to clearly identify patients who will benefit from an early intervention. “We should stratify patients and go for Child B more than 7 points with active bleeding to place the TIPS,” Dr. Hernández-Gea said.

Patients with Child B without bleeding do not benefit from preemptive TIPS. Patients with a Child B greater than 7 have the greatest survival benefit undergoing preemptive TIPS.
In an American study evaluating 5,529 patients,3 mortality is correlated with the number of TIPS placements at the institution. Hospitals placing more than 20 TIPS per year have lower mortality rates. Therefore, in the best interest of the patient, said Dr. Hernández-Gea, hospitals that place only a few TIPS per year should refer these patients to centers of expertise.

View part 1 View part 3 See the full webinar and transcript
 

Interested in speaking with a

Cook Medical representative?

Please click the button below and submit the required information to connect with your local Cook representative. This form is intended for US-based physicians only.

References

  1. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterol. 1981;80(4):800-809.
  2. Nicoara-Farcau O, Han G, Rudler M, et al. Effects of early placement of transjugular portosystemic shunts in patients with high-risk acute variceal bleeding: a meta-analysis of individual patient data. Gastroenterol. 2021;160(1):193-205.e10. doi: 10.1053/j.gastro.2020.09.026.
  3. 3. Sarwar A, Zhou L, Novack V, et al. Hospital volume and mortality after transjugular intrahepatic portosystemic shunt creation in the United States. Hepatology. 2018;67(2):690-699. doi: 10.1002/hep.29354.